AI-generated summary
The authors reviewed 50 studies of secondary-care treatments for primary hyperhidrosis, including iontophoresis, botulinum toxin, anticholinergic medications, curettage and energy-based technologies. They report that evidence overall is limited, with most studies small, at high risk of bias and poorly reported. They describe moderate-quality evidence supporting botulinum toxin for axillary hyperhidrosis.
- Studies included
- 50
- Who or what was studied
- People with primary hyperhidrosis treated in secondary care
- Limits stated in the abstract
- Most included studies were small, at high risk of bias and poorly reported, so few firm conclusions can be drawn.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on academic.oup.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Systematic review, Risk of bias, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.